Results 321 to 330 of about 155,757 (387)

Tear fluid calcitonin gene-related peptide (CGRP) is elevated during spontaneous migraine attacks - results from a pilot study. [PDF]

J Headache Pain
Kamm K, Brandi-Dohrn A, Straube A, Förderreuther S, Ruscheweyh R.   +4 more
europepmc   +1 more source

Errors in Specificity/Sensitivity Labels in Text, Table 2, and Figure 2.

JAMA Otolaryngol Head Neck Surg
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

History and Review of anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: From Translational Research to Treatment

Headache, 2018
Objective – To briefly describe the history of and available data on anti‐calcitonin gene‐related peptide (CGRP) therapies for headache.
S. Tepper
exaly   +2 more sources

Targeting calcitonin gene-related peptide: a new era in migraine therapy

Lancet, The, 2019
Andrew Charles, Patricia Pozo-Rosich
exaly   +2 more sources

Calcitonin

Current Medicinal Chemistry, 1999
The peptide calcitonin (CT) was initially discovered in 1962 as a novel hypocalcemic hormone. This hypocalcemic response was principally due to a potent inhibitory action of CT on osteoclast mediated bone resorption and it is this action which underlies its widespread clinical use for the treatment of bone disorders, including Paget's ...
Findlay, D., Sexton, P., Martin, T.
openaire   +3 more sources